SCHEMBL457128

SCHEMBL457128

COc1ccc(CCC(=O)Oc2cc(O)cc(O)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 2/20 0.62
SLC5A2 P31639 2/20 0.62
CALM1 P0DP23 3/20 0.62
NFKB1 P19838 1/20 0.60
NFKB2 Q00653 1/20 0.60
RELA Q04206 1/20 0.60
F2RL1 P55085 1/20 0.55
FFAR1 O14842 1/20 0.52
MAPT P10636 3/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14877832 0.88 CALM1 (0.62) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL11246900 0.88 CALM1 (0.62) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL457502 0.86 SLC5A1 (0.55) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL15094539 0.86 GPR84 (0.47) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL14877841 0.85 NFKB1 (0.57) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL456324 0.84 GABRA1 (0.58) MAPTALDH1A1TDP1
SCHEMBL15094007 0.84 GPR84 (0.51) SLC5A1SLC5A2CALM1KMT2APOLB
SCHEMBL455621 0.83 FFAR1 (0.50) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL454233 0.83 AKR1C3 (0.45) SLC5A1SLC5A2CALM1NFKB1NFKB2
SCHEMBL458223 0.83 SLC5A1 (0.55) SLC5A1SLC5A2CALM1FFAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10800725-B2 Arylpropionyl-triketone antibacterial agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-10-13 US disclosed
US-20130289128-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-10-31 US disclosed
WO-2012033846-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130289128-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS POLR2H, POLR2A, POLR2E SLC5A1 2423/4885SLC5A2 3409/4885CALM1 4400/4885
US-10800725-B2 Arylpropionyl-triketone antibacterial agents POLR2H, POLR2A, POLR2E SLC5A1 2423/4885SLC5A2 3409/4885CALM1 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.